Typicality: | 0.363 |
Saliency: | 0.265 |
for initiation of antibody development | 3 | purpose |
directly | 2 | manner |
vaccine → be based on → dendritic cells | 6 |
vaccine → activate → dendritic cells | 5 |
vaccine → target → dendritic cells | 5 |
vaccine → use → dendritic cells | 5 |
negative | neutral | positive |
0.086 | 0.741 | 0.173 |
Raw frequency | 21 |
Normalized frequency | 0.265 |
Modifier score | 0.500 |
Perplexity | 60.881 |